Person:
ŞEKERCİ, ABDÜSSELAM

Loading...
Profile Picture
Google ScholarScopusORCIDPublons
Status
Organizational Units
Organizational Unit
Job Title
First Name
ABDÜSSELAM
Last Name
ŞEKERCİ
Name
Email Address
Birth Date

Search Results

Now showing 1 - 2 of 2
  • PublicationMetadata only
    PREMENOPOZAL KADINLARDA SIK GÖRÜLEN DEMİR EKSİKLİĞİ ANEMİSİNDE SORUN VİTAMİN K EKSİKLİĞİ OLABİLİR Mİ?
    (2018-10-10T00:00:00Z) KARATOPRAK, CUMALİ; KARAASLAN, TAHSİN; ŞEKERCİ, ABDÜSSELAM; OLGAÇ, ATİLLA; KARATOPRAK, CUMALİ; ŞEKERCİ, ABDÜSSELAM
  • PublicationMetadata only
    Is there a link between neutrophil-lymphocyte ratio and patient compliance with gluten free diet in celiac disease?
    (2016-01-01T00:00:00Z) Uslu, Ali Ugur; Korkmaz, Serdal; Yonem, Ozlem; Aydin, Bahattin; Uncu, Tunahan; Sekerci, ABDÜSSELAM; Topal, Firdevs; ŞENCAN, MEHMET; ŞEKERCİ, ABDÜSSELAM
    © Gülhane Tip Fakültesi 2016.The aim of the present study is to determine the association of neutrophillymphocyte ratio (NLR) as an objective marker for detecting compliance to diet in celiac disease (CD). Thirty-seven patients with CD and 37 healthy volunteers were enrolled to the study. At the end of the first year, the patients were divided into 2 groups considering their compliance with diet. Seven patients, who are not compliant to gluten free diet (GFD), formed the first group (group 1). Thirty patients, who are compliant to GFD, formed the second group (group 2), and 37 healthy volunteers served as the control group (group 3). NLR was significantly higher in the patient group than the controls (p 0.05). At the end of the first year, there were significant differences between group 1 and group 2 (p = 0.007) and between group 1 and group 3 in terms of NLR (p = 0.005). Receiver-operating characteristic curve analysis suggested the optimum NLR cutoff value for patients with GFD incompatible as 2.51, with a sensitivity and specificity of 85 % and 94 %, respectively (area under curve: 0.819, 95 % confidence interval = 0.589-1.000, p = 0.009). NLR may be a promising marker in predicting the patient compliance in patients with CD.